 |
DDAH I (C-19) 抗体: sc-26068 |
| データシート |
|
- goat polyclonal IgG, 200 µg/ml
- epitope mapping within an internal region of DDAH I of human origin
- recommended for detection of DDAH I of mouse, rat and human origin by WB, IP, IF and ELISA; also reactive with additional species, including equine, canine, bovine, porcine and avian
- blocking peptide, sc-26068 P
|
|
| |
注文情報参考文献
お奨めサポート品
(お好みのアプリケーションボタンをクリックして下さい)
DDAH I Background Information
DDAH, a dimethylarginine dimethylaminohydrolase, hydrolyzes dimethyl arginine (ADMA) and monomethyl arginine (MMA), both inhibitors of nitric oxide synthases, and may be involved in in-vivo modulation of nitric oxide production (1,2). Impairment of DDAH causes ADMA accumulation and a reduction in cGMP generation (3). DDAH II, the predominant DDAH isoform in endothelial cells, facilitates the induction of nitric oxide synthesis by all-trans-Retinoic acid (atRA) (4). DDAH proteins are highly expressed in colon, kidney, stomach and liver tissues (1).
|
他の研究者が、DDAH I (C-19): sc-26068抗体およびDDAH I (C-19)のconjugate抗体をどのように使用したかを見る。
2 total citations Loading citations.
|
| |
|
|
|
DDAH I (C-19)
画像をクリックして拡大する
|
DDAH I (C-19): sc-26068. Western blot analysis of DDAH I expression in non-transfected: sc-117752 (A) and mouse DDAH I transfected: sc-119696 (B) 293T whole cell lysates. |
|
Download
|
|
